AMBRA1 levels predict resistance to MAPK inhibitors in melanoma.
Di Leo L, Pagliuca C, Kishk A, Rizza S, Tsiavou C, Pecorari C, Dahl C, Pacheco MP, Tholstrup R, Brewer JR, Berico P, Hernando E, Cecconi F, Ballotti R, Bertolotto C, Filomeni G, Gjerstorff MF, Sauter T, Lovat P, Guldberg P, De Zio D.
Di Leo L, et al. Among authors: pecorari c.
Proc Natl Acad Sci U S A. 2024 Jun 18;121(25):e2400566121. doi: 10.1073/pnas.2400566121. Epub 2024 Jun 13.
Proc Natl Acad Sci U S A. 2024.
PMID: 38870061